v3.25.4
Non-Derivative Fair Value Measurements (Nonrecurring Fair Value Measurements) (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended
Mar. 31, 2025
Dec. 31, 2024
Sep. 30, 2023
Mar. 31, 2025
Dec. 31, 2024
Sep. 30, 2023
Dec. 31, 2025
Dec. 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                
Long-lived assets, carrying amount   $ 138,852.0     $ 138,852.0   $ 156,197.0 $ 125,776.0
Investment in equity method investees   6,118.0     6,118.0   5,528.0 $ 6,156.0
NEER                
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                
Investment in equity method investees   $ 2,838.0     2,838.0   $ 2,123.0  
NEER | XPLR                
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                
Fair Value Measurement, Trading Price, Per Share $ 9.50 $ 17.80 $ 29.70          
Investment in equity method investees $ 1,700.0 $ 2,600.0 $ 4,200.0 $ 1,700.0 2,600.0 $ 4,200.0    
Equity Method Investment, Other than Temporary Impairment, After Tax       500.0 600.0 900.0    
Equity Method Investments, Fair Value Disclosure $ 1,000.0 $ 1,800.0 $ 3,000.0 1,000.0 1,800.0 3,000.0    
Equity Method Investment, Other than Temporary Impairment       $ 700.0 $ 800.0 $ 1,200.0